The Squirrel Monkey: Characterization of a New-World Primate Model of Experimental Choroidal Neovascularization and Comparison with the Macaque

Investigative Ophthalmology and Visual Science

Volumn 45, Issue 2, 2004, Pages 625-634

  Criswell, Mark H ^a   Ciulla, Thomas A ^a   Hill, Tiffany E ^a   Small, Ward ^b   Danis, Ronald P ^a   Snyder, Wendy J ^b   Lowseth, Lisa A ^c   Carson, Dennis L ^c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Miravant Medical Technologies   (United States)

^c ALCON RESEARCH LTD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY; EYE FUNDUS; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HISTOLOGY; LASER COAGULATION; MACACA; MALE; NONHUMAN; PRIMATE; PRIORITY JOURNAL; RETINA MACULA LUTEA; SQUIRREL MONKEY; SUBRETINAL NEOVASCULARIZATION;

ANIMALS; CHOROID; CHOROIDAL NEOVASCULARIZATION; DISEASE MODELS, ANIMAL; FEMALE; FIBROSIS; FLUORESCEIN ANGIOGRAPHY; FUNDUS OCULI; LASER COAGULATION; MACACA FASCICULARIS; MALE; RETINA; SAIMIRI;

EID: 0942287235     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.03-0718     Document Type: Article

References (69)

1. Wolin LR, Massopust LR Jr. Characteristics of the ocular fundus in primates. J Anat. 1967;101:693-699.
2. Stone J, Johnston E. The topography of primate retina: a study of the human, bushbaby, and New- and Old-World monkeys. J Comp Neurol. 1981;196:205-223.
3. Krebs IP, Krebs W. Discontinuities of the external limiting membrane in the fovea centralis of the primate retina. Exp Eye Res. 1989;48:295-301.
4. Ryan SJ. The development of an experimental model of subretinal neovascularization in disciform macular degeneration. Trans Am Ophthalmol Soc. 1979;77:707-745.
5. Ryan SJ. Subretinal neovascularization, natural history of an experimental model. Arcb Ophthalmol. 1982;100:1804-1809.
6. Ohkuma H, Ryan SJ. Experimental subretinal neovascularization in the monkey. Arcb Ophthalmol. 1983;101:1102-1110.
7. Ishibashi T, Koichiro M, Sorgente N, Patterson R, Ryan SJ. Effects of intravitreal administration of steroids on experimental subretinal neovascularization in the subhuman primate. Arcb Ophthalmol. 1985;103:708-711.
8. Miller H, Miller B Ryan SJ. Correlation of choroidal subretinal neovascularization with fluorescein angiography. Am J Ophthalmol. 1985;99:263-271.
9. Miller H, Miller B, Ryan SJ. Newly formed subretinal vessels. Invest Ophthalmol Vis Sci. 1986;27:204-213.
10. Miller H, Miller B, Ryan SJ. The role of retinal pigment epithelium in the involution of subretinal neovascularization. Invest Ophthalmol Vis Sci. 1986;27:1644-1652.
11. Ishibashi T, Miller H, Orr G, Sorgente N, Ryan SJ. Morphologic observations of experimental subretinal neovascularization in the monkey. Invest Ophthalmol Vis Sci. 1987;28:1116-1130.
12. Miller H, Miller B, Ishibashi T, Ryan SJ. Pathogenesis of laser-induced choroidal subretinal neovascularization. Invest Ophthalmol Vis Sci. 1990;31:899-908.
13. Nishimura T, Goodnight R, Prendergast RA, Ryan SJ. Activated macrophages in experimental subretinal neovascularization. Ophthalmologica. 1990;200:39-44.
14. Nishimura T, Zhu ZR, Ryan SJ. Effects of sodium iodate on experimental subretinal neovascularization in the primate. Ophthalmologica. 1990;200:28-38.
15. Martini B, Ryan SJ. Argon laser lesions of the retina; occurrence and origin of macrophages. Eur J Ophthalmol. 1992;2:51-57.
16. Taiji S, Danilo S, Nassaralla J, et al. Effect of intravitreal administration of indomethacin on experimental subretinal neovascularization in the subhuman primate. Arcb Ophthalmol. 1995;113:222-226.
17. Murata T, Cui J, Taba KE, et al. The possibility of gene therapy for the treatment of choroidal neovascularization. Ophthalmology. 2000;107:1364-1373.
18. Miller JW, Walsh AW, Kramer M, et al. Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin. Arch Ophthalmol. 1995;113:810-818.
19. Husain D, Miller JW, Michaud N, et al. Intravenous infusion of liposomal benzoporphyrin derivative for photodynamic therapy of experimental choroidal neovascularization. Arcb Ophthalmol. 1996;114:978-985.
20. Kramer M, Miller JW, Michaud N, et al. Liposomal benzoporphyrin derivative verteporfin photodynamic therapy: selective treatment of choroidal neovascularization in monkeys. Ophthalmology. 1996;103:427-438.
21. Husain D, Kramer M, Kenny AG, et al. Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to 7 weeks after treatment. Invest Ophthalmol Vis Sci. 1999;40:2322-2331.
22. Tolentino MJ, Husain D, Theodosiadis P, et al. Angiography of fluoresceinated anti-vascular endothelial growth factor and dextrans in experimental choroidal neovascularization. Arch Ophthalmol. 2000;118:78-84.
23. Baskin GB. Pathology of Nonhuman Primates. Primate Info Net, Wisconsin Region primate Research Center, University of Wisconsin-Madison. Available at: http://www.primate.wisc.edu/pin/pola6-99.html. Accessed October 11, 2001.
24. Ryan SJ. Subretinal neovascularization after argon laser photocoagulation. Graefes Arch Clin Exp Ophthalmol. 1980;215:29-42.
25. Peyman GA, Kazi AA, Unal M, et al. Problems with and pitfalls of photodynamic therapy. Ophthalmology. 2000;107:29-35.
26. Dobi ET, Puliafito CA, Destro M. A new model of experimental choroidal neovascularization in the rat. Arch Ophthalmol. 1989;107:264-269.
27. Roider J, El Hifnawi ES, Birngruber R. Bubble formation as primary interaction mechanism in retinal laser exposure with 200-ns laser pulses. Lasers Surg Med. 1998;22:240-248.
28. Tobe T, Ortega S, Luna JD, et al. Targeted disruption of the FGF2 Gene does not prevent choroidal neovascularization in a murine model. Am J Pathol. 1998;153:1641-1646.
29. Tombran-Tink J, Chader GG, Johnson LV. PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity. Exp Eye Res. 1991;53:411-414.
30. Dawson DW, Volpert OV, Gillis P, Crawford, et al. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 1999;285:245-248.
31. Mori K, Duh E, Gehlbach P, et al. Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization. J Cell Physiol. 2001;188:253-263.
32. Tombran-Tink J, Barnstable CJ. PEDF: a multifaceted neurotrophic factor. Nat Rev Neurosci. 2003;4:628-636.
33. Steen B, Sejersen S, Berglin L, Seregard S, Kvanta A. Matrix metalloproteinases and metalloproteinase inhibitors in choroidal neovascular membranes. Invest Ophthalmol Vis Sci. 1998;39:2194-2200.
34. Kadonosono K, Yazama F, Itoh N, Sawada H, Ohno S. Expression of matrix metalloproteinase-7 in choroidal neovascular membranes in age-related macular degeneration. Am J Ophthalmol. 1999;128:382-384.
35. Kvanta A, Shen WY, Sharman S, Seregard S, Steen B, Rakoczy E. Matrix metalloproteinase (MMP) expression in experimental choroidal neovascularization. Curr Eye Res. 2000;21:684-690.
36. Takahashi T, Nakamura T, Hayashi A, et al. Inhibition of experimental choroidal neovascularization by overexpression of tissue inhibitor of metalloproteinases-3 in retinal pigment epithelium cells. Am J Ophthalmol. 2000;130:774-781.
37. Ahir A, Guo L, Hussain AA, Marshall J. Expression of Metalloproteinases from human retinal pigment epithelial cells and their effects on the hydraulic conductivity of Bruch's membrane. Invest Ophthalmol Vis Sci. 2002;43:458-465.
38. Lambert V, Munaut C, Jost M, et al. Matrix metalloproteinase-9 contributes to choroidal neovascularization. Am J Pathol. 2002;161:1247-1253.
39. Berglin L, Sharman S, van der Ploeg I, et al. Reduced choroidal neovascular membrane formation in matrix metalloproteinase-2-deficient mice. Invest Ophthalmol Vis Sci. 2003;44:403-408.
40. Peyman GA, Li M, Yoneya S, Goldberg MF, Raichand M. Fundus photocoagulation with the argon and krypton lasers: a comparative study. Ophthalmic Surg. 1981;12:481-490.
41. Folk JC, Shortt SG, Kleiber PD. Experiments on the absorption of argon and krypton laser by blood. Ophthalmology. 1985;92:100-108.
42. Chino K, Ohki R, Noyori K. Krypton and argon laser photocoagulation effects in subretinal hemorrhage. Jpn J Ophthalmol. 1986;30:282-287.
43. Obana A, Gohto Y, Kaneda K, Nakajima S, Miki T. PDT to monkey CNV with ATX-S10(Na): inappropriateness of early laser irradiation for selective occlusion. Invest Ophthalmol Vis Sci. 2001;42:2639-2645.
44. Feeney-Burns L, Malinow MR, Klein ML, Neuringer M. Maculopathy in cynomolgus monkeys, a correlated fluorescein angiographic and ultrastructural study. Arcb Ophthalmol. 1981;99:664-672.
45. Weinhaus RS, Burke JM, Delori FC, Snodderly DM. Comparison of fluorescein angiography with microvascular anatomy of macaque retinas. Exp Eye Res. 1995;61:1-16.
46. Lai WW, Shahidi M, Mori M, Pulido JS. Chorioretinal topography and histopathology in laser-induced choroidal neovascularization. Ophthalmic Surg Lasers. 2003;34:38-43.
47. Shen W-Y, Garrett KL, Wang C-G, et al. Preclinical evaluation of a phosphorothioate oligonucleotide in the retina of rhesus monkey. Lab Invest. 2002;82:167-182.
48. Chang AA, Morse LS, Handa JT, et al. Histologic localization of indocyanine green dye in aging primate and human ocular tissues with clinical angiographic correlation. Ophthalmology. 1998;105:1060-1068.
49. Edelman JL, Castro MR. Quantitative image analysis of laser-induced choroidal neovascularization in rat. Exp Eye Res. 2000;71:523-533.
50. Ciulla TA, Criswell MH, Danis RP, Hill TE. Intravitreal triamcinolone acetonide inhibits choroidal neovascularization in a laser-treated rat model. Arch Ophthalmol. 2001;119:399-404.
51. Burnside B, Laties AM. Actin filaments in apical projections of the primate pigmented epithelial cell. Invest Ophthalmol. 1976;15:570-575.
52. Wallow IH. Repair of the pigment epithelial barrier following photocoagulation. Arch Ophthalmol. 1984;102:126-135.
53. Ziccardi M, Lourenco-de-Oliveira R. The infection rates of trypanosomes in squirrel monkeys at two sites in the Brazilian Amazon. Mem Inst Oswaldo Cruz. 1997;92:465-470.
54. Crawford MLJ. Central vision of man and macaque: cone and rod sensitivity. Brain Res. 1977;119:345-356.
55. Bowmaker JK, Dartnall HJA, Mollon JD. Microspectrophotometric demonstration of four classes of photoreceptors in an Old World primate, Macaca fascicularis. J Physiol (Lond). 1980;298:131-143.
56. Baylor DA, Nunn BJ, Schnapf JL. Spectral sensitivity of cones of the monkey Macaca fascicularis. J Physiol (Lond). 1987;390:145-160.
57. Hárosi FI. Cynomolgus and rhesus monkey visual pigments: application of Fourier transform smoothing and statistical techniques to the determination of spectral parameters. J Gen Physiol. 1987;89:717-743.
58. Cowey A, Ellis CM. Visual acuity of rhesus and squirrel monkeys. J Comp Physiol Psychol. 1967;64:80-84.
59. Woodburne LS. Visual acuity of "Saimiri sciureus". Psychon Sci. 1965;3:307-308.
60. Rolls ET, Cowey A. Topography of the retina and striate cortex and its relationship to visual acuity in rhesus monkeys and squirrel monkeys. Exp Brain Res. 1970;10:298-310.
61. Snodderly DM, Weinhaus RS. Retinal vasculature of the fovea of the squirrel monkey, Saimiri sciureus: three-dimensional architecture, visual screening, and relationships to the neuronal layers J Comp Neurol. 1990;297:145-163.
62. Leventhal AG, Thompson KG, Liu D. Retinal ganglion cells within the foveola of New World (Saimiri sciureus) and Old World (Macaca fascicularis) monkeys. J Comp Neurol. 1993;338:242-254.
63. Reinke MH, Canakis C, Husain D, et al. Verteporfin photodynamic therapy retreatment of normal retina and choroid in the cynomolgus monkey. Ophthalmology 1999;106:1915-1923.
64. Peyman GA, Kazi AA, Moshfeghi D, et al. Threshold and retreatment parameters of NPe6 photodynamic therapy in retinal and choroidal vessels. Ophthalmic Surg Lasers. 2000;31:323-327.
65. Nakashizuka T, Mori K, Hayshi N, et al. Retreatment effect of NPe6 photodynamic therapy on the normal primate macula. Retina. 2001;21:493-498.
66. Mori K, Yoneya S, Anzail K, et al. Photodynamic therapy of experimental choroidal neovascularization with a hydrophilic photosensitizer: mono-D-aspartyl chlorin e6. Retina. 2001;21:499-508.
67. Obana A, Gohto Y, Kanai M, et al. Selective photodynamic effects of the new photosensitizer ATX-S10(Na) on choroidal neovascularization in monkeys. Arch Ophthalmol. 2000;118:650-658.
68. Ciulla TA, Criswell MH, Danis RP, Snyder WJ, Small W. Evaluation of photosensitizer MV6401, indium chloride methyl pyropheophorbide as a photodynamic therapy agent in primate choriocapillaris and laser-induced choroidal neovascularization. Retina. In press.
69. Warfvinge K, Szél Á, Bruun A. Histopathological and immunocytochemical demonstration of retinal degeneration in the squirrel monkey. Exp Eye Res. 1996;63:245-253.